InnoCare Pharma Limited (HKG: 9969)
Hong Kong
· Delayed Price · Currency is HKD 5.60
-0.09 (-1.58%)
Jan 3, 2025, 4:08 PM HKT
InnoCare Pharma Revenue
InnoCare Pharma had revenue of 278.01M CNY in the quarter ending September 30, 2024, with 73.96% growth. This brings the company's revenue in the last twelve months to 898.92M, up 24.65% year-over-year. In the year 2023, InnoCare Pharma had annual revenue of 738.54M with 18.09% growth.
Revenue (ttm)
898.92M CNY
Revenue Growth
+24.65%
P/S Ratio
9.63
Revenue / Employee
825.46K CNY
Employees
1,089
Market Cap
11.67B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 26.04B |
| Hansoh Pharmaceutical Group Company | 13.00B |
| JD Health International | 58.84B |
| WuXi Biologics | 18.39B |
| Sinopharm Group | 634.32B |
| Innovent Biologics | 8.01B |
| Sino Biopharmaceutical | 29.86B |
| CSPC Pharmaceutical Group | 33.53B |